Trial Profile
Real life, 48-week, prospective, observational, single-cohort study of effectiveness and safety of fixed combination Amlodipine/ Irbesartan in the management of Hypertension in Latin America
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms Parceria
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results presented at the 28th European Meeting on Hypertension and Cardiovascular Protection